Chong Kun Dang Pharmaceutical
185750.KO
60.16 USD
0.78
+1.31%
c
Overview
Last close
60.16 usd
Market cap
792.64M usd
52 week high
71.97 usd
52 week low
48.18 usd
Target price
80.72 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.3666
Price/Book Value
1.1709
Enterprise Value
810.49M usd
EV/Revenue
0.707
EV/EBITDA
8.9866
Key financials
Revenue TTM
582.55M usd
Gross Profit TTM
231.27M usd
EBITDA TTM
67.52M usd
Earnings per Share
N/A usd
Dividend
0.34 usd
Total assets
1.25B usd
Net debt
98.28M usd
About
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
- Symbol185750.KO
- ExchangeKO
- IsinKR7185750007
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Young-Joo Kim
- HeadquarterSeoul
- Web sitehttps://www.ckdpharm.com
Related indices
Related news
November 18
JAKOTA Stocks on November 17, 2023 